A letter from HHS Secretary Robert F Kennedy Jr. and FDA Commissioner Martin Makary, in which they confirmed that the FDA is ...
Continued low fertility rates will cause ‘a gradual implosion of the world’s economy as the population ages and dies’, said ...
Planned Parenthood of Wisconsin will stop scheduling patients for abortions starting next week as it works to find a way to ...
Currently, telehealth accounts for a quarter of abortions in the U.S., and in 2023, nearly two-thirds of abortions were done ...
The Trump administration said it will review the medication abortion drug mifepristone (Mifeprex) to see whether current ...
In less than a week, Planned Parenthood will pause its abortion appointments in Wisconsin. Once that happens, one expert said it will lead to more Wisconsinites seeking abortions ...
One such study, conducted by the Ethics and Public Policy Center, analyzed insurance data and found nearly 11% of patients ...
17hon MSN
FDA reviews abortion pill
The FDA is studying the safety of abortion drug mifepristone, driving new concerns about limits on access. New virus strain spikes in 9 US states with symptoms from brain fog to persistent cough ...
Secretary Robert F. Kennedy Jr. has directed the Food and Drug Administration (FDA) to conduct a review into the safety evidence of ...
Data analyzed by CNN shows mifepristone — the first drug in the medication abortion process — is even safer than some common, low-risk prescription drugs, including penicillin and Viagra.
HHS and FDA launch review of abortion pill mifepristone after disputed safety study, sparking backlash from abortion rights advocates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results